OrganOx was spun out from the University of Oxford in April 2008 and has developed the world’s first normothermic liver perfusion device, the Metra, approved for storage and transportation of human livers prior to transplant.

The technology, which is also being developed for the normothermic perfusion of kidneys, has the potential to disrupt the transplant market, significantly increasing the supply of viable organs by overcoming several major limitations in existing methods. The 220-patient European clinical trial data was published in the prestigious academic journal Nature in 2Q 2018 and will be used to accelerate US FDA certification, expected in mid-2021.

Visit website